We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

79 hedge funds and large institutions have $332M invested in TG Therapeutics in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 18

71% more call options, than puts

Call options by funds: $5.45M | Put options by funds: $3.19M

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

12% more capital invested

Capital invested by funds: $296M → $332M (+$36.3M)

5% more funds holding

Funds holding: 75 → 79 (+4)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
79
Holders Change
+4
Holders Change %
+5.33%
% of All Funds
2.1%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
14
Increased
40
Reduced
18
Closed
10
Calls
$5.45M
Puts
$3.19M
Net Calls
+$2.27M
Net Calls Change
-$4.27M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$19.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.2M
3
SAM
Sectoral Asset Management
Quebec, Canada
+$6.6M
4
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
+$4.92M
5
BM
Bridger Management
New York
+$4.11M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$12.6M
2
HH
HWG Holdings
Texas
-$3.89M
3
RCM
RA Capital Management
Massachusetts
-$3.41M
4
Barclays
Barclays
United Kingdom
-$2.69M
5
EAM
EverPoint Asset Management
Connecticut
-$2.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFPIA
76
Stevens First Principles Investment Advisors
California
$8K +$7.57K +500 New
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$3K +$3.03K +200 New
PNC Financial Services Group
78
PNC Financial Services Group
Pennsylvania
$2K – – –
Manulife (Manufacturers Life Insurance)
79
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$272 +$29.6K +1,952 +12%
JP Morgan Chase
80
JP Morgan Chase
New York
– -$12.6M -798,361 Closed
EAM
81
EverPoint Asset Management
Connecticut
– -$2.45M -154,689 Closed
MNBTD
82
Moody National Bank Trust Division
Texas
– -$1.33M -84,149 Closed
ARTA
83
A.R.T. Advisors
New York
– -$922K -58,245 Closed
DC
84
Deere & Company
Illinois
– -$524K -33,089 Closed
Simplex Trading
85
Simplex Trading
Illinois
– -$133K -8,776 Closed
BRWA
86
B. Riley Wealth Advisors
Florida
– -$124 -7,823 Closed
SG Americas Securities
87
SG Americas Securities
New York
– -$109K -6,905 Closed
CSS
88
Cubist Systematic Strategies
Connecticut
– -$7K -442 Closed
Janus Henderson Group
89
Janus Henderson Group
United Kingdom
– -$5K -296 Closed
1 2 3
4

TGTX Hedge Fund Activity: Q1 2015 in Review

79 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q1 2015, worth a combined $332M — up 12% from $296M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new TGTX positions and 10 closed out — a net gain of 4 holders — while 40 added to existing stakes and 18 trimmed.

The largest buyer was State Street, adding an estimated $19.9M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $12.6M sold.

  • 79 institutional investors held TG Therapeutics (TGTX) as of Q1 2015, up from 75 in Q4 2014.
  • Funds reported $332M of TG Therapeutics stock for Q1 2015, up 12% quarter-over-quarter.
  • 14 funds opened new TG Therapeutics positions in Q1 2015 and 10 closed out, a net change of +4 holders.
  • The largest TG Therapeutics buyer in Q1 2015 was State Street, an estimated $19.9M added.
  • The largest TG Therapeutics seller in Q1 2015 was JP Morgan Chase, an estimated $12.6M sold.

Based on aggregated 13F filings for Q1 2015.